JEWISH TIME PODCAST JEWISH TIME PODCAST SUBSCRIBE TODAY SUBSCRIBE TODAY
search
Rick Doblin
Rick Doblin has spent his entire adult life working to restore the scientific reputation of psychedelics.
December 14, 2023, 10:29 am
New Psychedelic Revolution Leader Contemplates Success
After over 37 years of research and education, Rick Doblin and the organization he founded has submitted the first application for the approval of a psychedelic drug in U.S. medical history.
By Bob Bahr
Psilocybin, a psychedelic derived from mushrooms, is being tested in Atlanta for drug-resistant depression.
July 12, 2023, 1:06 pm
Psychedelics Get New Respect from Medical Researchers
Research on psychedelics is an important part of a national effort to treat chronic PTSD and depression.
By Bob Bahr
The experimental use of the hallucinogenic drug is being explored in a wide range of conditions.
May 11, 2022, 2:38 pm
A Psychedelic Head Trip May Be in Your Medical Future
Medical researchers are seriously exploring the use of psychedelic mushrooms for a wide range of physical and mental ailments.
By Bob Bahr
MDMA is on a fast track for FDA approval as a treatment for PTSD.
June 29, 2021, 8:21 pm
Psychedelics Get New Medical Respect
Research at Emory University shows particular promise for the use of MDMA, a popular illegal recreational drug, to help cure PTSD.
By Bob Bahr
Load More